We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
From May 2019 to May 2024
TIDMGSK
RNS Number : 7908X
GlaxoSmithKline PLC
01 May 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Sir Philip Hampton
=== ======================== ===========================================
b) Position/status Non-Executive Chairman
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 January
2019 to 31 March 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.68 2,790.179
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-05-01
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr Vindi Banga
=== ======================== ===========================================
b) Position/status Senior Independent Non-Executive Director
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 January
2019 to 31 March 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.68 458.386
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-05-01
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Dr Vivienne Cox
=== ======================== ===========================================
b) Position/status Independent Non-Executive Director
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 January
2019 to 31 March 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.68 338.807
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-05-01
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Ms Lynn Elsenhans
=== ======================== ===============================================
b) Position/status Independent Non-Executive Director
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 January 2019 to 31 March
2019.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$40.67 1,174.570
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-05-01
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Dr Laurie Glimcher
=== ======================== ===============================================
b) Position/status Independent Non-Executive Director
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 January 2019 to 31 March
2019.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$40.67 1,351.687
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-05-01
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
========================================================================
a) Name Dr Jesse Goodman
=== ======================== ==============================================
b) Position/status Independent Non-Executive Director
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ==============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 January 2019 to 31 March
2019.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$40.67 407.837
----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2019-05-01
=== ======================== ==============================================
f) Place of the n/a
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
========================================================================
a) Name Ms Judy Lewent
=== ======================== ==============================================
b) Position/status Independent Non-Executive Director
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ==============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 January 2019 to 31 March
2019.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$40.67 454.447
----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2019-05-01
=== ======================== ==============================================
f) Place of the n/a
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr Urs Rohner
=== ======================== ===========================================
b) Position/status Independent Non-Executive Director
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 January
2019 to 31 March 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.68 458.386
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-05-01
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHZFLFBKEFBBBK
(END) Dow Jones Newswires
May 01, 2019 10:11 ET (14:11 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
